FIGSConsumer Cyclical · Apparel ManufacturingThe 9 Wall Street analysts covering FIGS, Inc. hold a median 12-month price target of $19 — +29.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 99 of 100 as at 22 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores FIGS, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (99): Analysts have, on balance, been raising their forecasts.
Issuance (46): The company has been issuing shares or taking on financing, diluting existing holders.
Size (34): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on FIGS, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +29.4% from it.
Of the 20 most recent actions, 4 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 7 Aug 2026 | Barclays | Maintains | Overweight | $17 → $20 |
| 7 Aug 2026 | BTIG | Maintains | Buy | $20 → $22 |
| 7 Aug 2026 | Keybanc | Maintains | Overweight | $19 → $20 |
| 7 Aug 2026 | Telsey Advisory Group | Maintains | Market Perform | $17 → $16 |
| 28 Apr 2026 | Keybanc | Maintains | Overweight | — |
| 28 Apr 2026 | Keybanc | Maintains | Overweight | $17 → $19 |
| 24 Apr 2026 | BTIG | Reiterates | Buy | $20 |
| 24 Apr 2026 | BTIG | Reiterates | Buy | — |
| 13 Apr 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 20 Mar 2026 | Oppenheimer | Upgrade | Outperform | — |
| 12 Mar 2026 | Telsey Advisory Group | Maintains | Market Perform | — |
| 4 Mar 2026 | BTIG | Maintains | Buy | — |
| 27 Feb 2026 | BTIG | Reiterates | Buy | — |
| 27 Feb 2026 | Keybanc | Upgrade | Overweight | — |
| 27 Feb 2026 | Telsey Advisory Group | Maintains | Market Perform | — |
| 20 Feb 2026 | Telsey Advisory Group | Maintains | Market Perform | — |
| 30 Jan 2026 | Goldman Sachs | Maintains | Sell | — |
| 13 Jan 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 6 Jan 2026 | Barclays | Maintains | Equal-Weight | — |
| 10 Dec 2025 | BTIG | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. FIGS appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 17% of US stocks
Cheaper than 38% of US stocks
Cheaper than 20% of US stocks
Cheaper than 10% of US stocks
Higher than 78% of US stocks
Higher than 93% of US stocks
Higher than 87% of US stocks
Higher than 76% of US stocks
Higher than 67% of US stocks
Higher than 74% of US stocks
Higher than 87% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own FIGS, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
FIGS' active customer base grew 13.2%, while stronger repeat engagement and broader product demand contributed to 28.8% revenue growth, according to Zacks Investment Research.
Why it matters — A FIGS watcher would care because expanding customer acquisition and repeat engagement signal growing demand for the company's products.
Figs (FIGS) shares have begun gaining and may continue rising in the near term, according to Zacks Investment Research, which points to solid earnings estimate revisions as the supporting indicator.
Why it matters — A FIGS watcher would care because positive earnings estimate revisions suggest improving analyst expectations for the company's near-term performance.
Zacks Investment Research reports the average of Wall Street analysts' price targets for Figs (FIGS) implies a potential upside of about 26.4%. The article notes that while the reliability of this price-target metric is questionable, the recent positive trend in earnings estimate revisions could support upside for the stock.
Why it matters — Figs watchers would care because analyst price targets and improving earnings estimate revisions are widely followed indicators of market sentiment toward the stock.
FIGS raised its 2026 outlook following strong second-quarter growth, setting higher revenue and margin targets even as it acknowledged second-half execution risks.
Why it matters — The upgraded outlook signals confidence in continued growth and profitability, making it a key development for investors tracking FIGS' financial trajectory.
FIGS is seeing accelerating growth and improving margins, but its high valuation creates a higher bar for continued stock gains.
Why it matters — A FIGS watcher would care because the company's operational momentum is balanced against the risk that its expensive stock price may limit future upside.
The 9 Wall Street analysts covering FIGS, Inc. have a median 12-month price target of $19, with estimates ranging from $15 to $22. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering FIGS, Inc., 5 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks FIGS, Inc. 99 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Aug 2026, FIGS, Inc. ranks 99 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (99 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies +29.4% from the last close, and Ticker Nerd's factor model ranks FIGS, Inc. 99 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering FIGS, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for FIGS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $15 to $22 over the next 12 months.
FIGS, Inc. returned +111.8% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Figs Inc. is a specialized apparel company focused on designing and selling stylish, high-performance medical scrubs and apparel.
The most recent item we track (Zacks Investment Research, 20 Aug 2026): "FIGS' Customer Base Expands as Repeat Engagement Strengthens". FIGS' active customer base grew 13.2%, while stronger repeat engagement and broader product demand contributed to 28.8% revenue growth, according to Zacks Investment Research.
Figs Inc. is a specialized apparel company focused on designing and selling stylish, high-performance medical scrubs and apparel. Its primary function is to provide healthcare professionals with comfortable, durable, and functional workwear that integrates innovative fabric technology. Known for its direct-to-consumer business model, Figs Inc. utilizes e-commerce to efficiently distribute its products, making it a notable player in the online retail space. The company emphasizes sustainability, ethical manufacturing practices, and social impact, often engaging in initiatives that support healthcare communities. Operating within the evolving healthcare and retail sectors, Figs Inc. taps into the growing demand for advanced medical apparel solutions. The brand has carved out a significant niche in the market, redefining traditional views of medical uniforms by blending fashion-forward design with utility. Established in Los Angeles, Figs Inc. is positioned as a leader in the niche industry of medical apparel, reflecting both the changing needs of healthcare professionals and the increasing importance of functional fashion in various professional fields.
CEO Ms. Catherine Eva Spear · 330 employees · United States · https://www.wearfigs.com